Glottic carcinoma limited to the vocal cords

Area of Science:

• Otolaryngology
• Radiation Oncology
• Head and Neck Cancer

Background:

• Early glottic carcinoma is typically treated with radiation therapy, with surgery reserved for treatment failures.
• Assessing the efficacy and outcomes of radiation therapy versus combined modality treatment is crucial for optimizing patient care.

Purpose of the Study:

• To evaluate the effectiveness of radiation therapy as a primary treatment for early glottic carcinoma.
• To compare local control and survival rates between radiation therapy alone and combined surgery-radiation approaches.
• To assess laryngeal function and voice quality outcomes in patients treated with radiation therapy.

Main Methods:

• Retrospective analysis of 150 cases of T1 glottic carcinoma.
• 138 patients received radiation therapy alone; outcomes were compared with those including surgery.
• Follow-up included assessment of survival, local control, and laryngeal preservation.

Main Results:

• Radiation therapy alone resulted in 88% 3-year and 77% 5-year survival rates.
• Local control was 82% after 6 years with radiation alone, increasing to 93% when surgery was included.
• Laryngeal preservation was achieved in 92% of survivors, with superior voice quality compared to postsurgical outcomes.

Conclusions:

• Radiation therapy alone is the treatment of choice for early glottic carcinomas due to comparable survival rates and better laryngeal function.
• The optimal radiation dose may be lower than currently recommended, warranting further investigation.
• Combined surgery-radiation offers higher local control but may compromise laryngeal function and voice quality.